Read + Share
Mancinelli CR, Scarpazza C, Cordioli C, De Rossi N, et al. Switching to ocrelizumab in RRMS patients at risk of PML previously treated with
extended interval dosing of natalizumab. Mult Scler 2021;27:790-794.
PMID: 32749910
|
 |
|
Mancinelli CR, Scarpazza C, Cordioli C, De Rossi N, et al. Switching to ocrelizumab in RRMS patients at risk of PML previously treated with
extended interval dosing of natalizumab. Mult Scler 2021;27:790-794.
PMID: 32749910
|
|
|
|